Prof. Hee Jung Kang, Korea
Improving pig red blood cell transfusion safety with anti-CD154 co-administration in nonhuman primates

Ms. Farzana Rahman, United States
Systemic inflammatory biomarkers versus graft specific hTBM in monitoring xenograft status

Dr. Anja MB Jensen, Denmark
Xenotransplantation hope: Flying pigs and the people who make it happen

Dr. Hyeonji Jeon, Korea
Brain-dead donors in xenotransplantation research: Global trends and legal-ethical challenges in Korea

Mr. Jun-Hyeong Kim, Korea
Production and characterization of transgenic pigs for xenotransfusion by knock-in of human CD46 and TBM or CD59 and CD47 genes at the GGTA1 exon4 locus

Dr. Sang Eun Kim, Korea
Blood-derived endothelial progenitor cells enable non-terminal verification of endothelial-specific transgene expression in GTKO/MCP/TBM pigs

Dr. KASINATH V KURAVI, United States
Generation of 10 gene pigs in one step with combination of CRISPR/CAS9 and 2A self-cleaving multigene expression system

Dr. Mayuko Kurome, Germany
Interspecies chimerism with human expanded potential stem cells in porcine embryos

Dr. Keon B Oh, Korea
Site-specific integration of HO1 and CD47 at the CMAH locus in GTKO pigs for immunomodulation in xenotransplantation

Joachim Denner, Germany
Expression of a retroviral immunosuppressive protein on the xenotransplant – A way to reduce pharmacological immunosuppression?

Heinke Heymer, Germany
LEA29Y expression affects myocardial scar formation after ischemia/reperfusion in pigs

Ms. Siwon Hwang, Korea
Bispecific anti-CD40LxCD28 antibody prevents mouse xenogeneic GVHD

Dr. Karen Khalil, United States
Dosing of pegcetacoplan with plasmapheresis for treatment of xenoantibody mediated rejection

Ji Woo Shin, Korea
Immunomodulatory ability of porcine peripheral blood-derived mesenchymal stem cells in xenotransplantation

Prof. Jai Young Cho, Korea
Impact of the high baseline anti-A/B antibody titer on the clinical outcomes in ABO-incompatible living donor liver transplantation

Dr. Yusuke Yanagino, Japan
Suppressive effect of mycophenolic acid on the cytotoxicity of human macrophages against swine endothelial cells

Dr. Daniel Hurst, United States
Attitudes toward pig islet xenotransplantation for type 1 diabetes: A scoping review

Dr. JI-JING YAN, Korea
Optimizing aCD154-free immunosuppression and monitoring in QKO pig-to-monkey islet xenotransplantation

Mr. Ivan J. Ma, Canada
Islet recovery and functionality retained after 24-hour static cold storage of neonatal porcine pancreas in University of Wisconsin solution

Juan OIFRPA Chen, People's Republic of China
Nanodelivery of IL 33 locally amplifies the ILC2 and Treg to protect the graft in islet transplantation

Dr. Jianmin Wu, People's Republic of China
Targeting the activity of beta cells by membrane surface redox regulation for islet transplantation

Dr. HAYK Harutyunyan, Armenia
Establishing a xenotransplantation program in Armenia to enhance surgical training and explore the role of polyamines in liver graft rejection

Prof. Elisabeth Kemter, Germany
Unravelling the dynamic process of NPI maturation at the single cell transcriptome level

Dr. W Lee, Korea
Genetic diversity and population structure of GTKO-engineered Xeno pigs across generations based on SNP analysis

Dr. Ernesto Goulart, Brazil
Preliminary results of obtaining designated pathogen-free pigs in a pig facility for xenotransplantation in Brazil

Dr. Ernesto Goulart, Brazil
Comparison of morphological quality of fetal fibroblasts fsed in nuclear transfer for swine embryo production for xenotransplantation

Robert C McCarthy, United States
A rational design method for tissue dissociation enzyme optimization (RDMTDE method)

Mr. Andrew G Breite, United States
An ancillary material supplier's perspective on ISO 20399:2022

Mrs. Ludmila Garcia, Brazil
Quality systems driving innovation: Implementing QMS, QA, and QC for genetically modified pigs in xenotransplantation

Dr. Ivana Juric, France
Mapping the evolution of solid organ xenotransplantation research: a systematic review

Dr. Sun Ae Hwang, Korea
Fabrication strategy of parathyroid organoids and their applicability for non-clinical primate transplantation